Comment
. 2006 Feb 1;42(3):431-2; author reply 432-3.
doi: 10.1086/499527.
How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?
- PMID: 16392093
- DOI: 10.1086/499527
Item in Clipboard
Comment
How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?
Clin Infect Dis.
.
No abstract available
Comment on
-
Rolling out antiretrovirals in Africa: there are still challenges ahead.Clin Infect Dis. 2005 Aug 1;41(3):386-9. doi: 10.1086/431490. Epub 2005 Jun 30. Clin Infect Dis. 2005. PMID: 16007537 No abstract available.
Similar articles
-
Called to account.Nature. 2004 Jul 8;430(6996):133. doi: 10.1038/430133a. Nature. 2004. PMID: 15241382 No abstract available.
-
Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?Clin Infect Dis. 2005 Dec 1;41(11):1683-4; author reply 1684. doi: 10.1086/498030. Clin Infect Dis. 2005. PMID: 16267745 No abstract available.
-
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.AIDS. 2008 Oct 18;22(16):2053-67. doi: 10.1097/QAD.0b013e328309520d. AIDS. 2008. PMID: 18753937 Review. No abstract available.
-
Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.Nat Med. 2003 Dec;9(12):1449-52. doi: 10.1038/nm1203-1449. Nat Med. 2003. PMID: 14647513 No abstract available.
-
A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Antiviral Res. 2008. PMID: 18571246 Review.
Cited by
-
Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.PLoS One. 2015 Jun 26;10(6):e0130649. doi: 10.1371/journal.pone.0130649. eCollection 2015. PLoS One. 2015. PMID: 26114436 Free PMC article. Clinical Trial.
-
Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.BMC Infect Dis. 2007 May 17;7:41. doi: 10.1186/1471-2334-7-41. BMC Infect Dis. 2007. PMID: 17509133 Free PMC article.
-
Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.BMC Public Health. 2007 Apr 25;7:63. doi: 10.1186/1471-2458-7-63. BMC Public Health. 2007. PMID: 17459154 Free PMC article.
-
The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.AIDS Res Ther. 2009 Jul 24;6:17. doi: 10.1186/1742-6405-6-17. AIDS Res Ther. 2009. PMID: 19630949 Free PMC article.
-
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.PLoS Med. 2007 Oct 16;4(10):e298. doi: 10.1371/journal.pmed.0040298. PLoS Med. 2007. PMID: 17941716 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
